Opthea Stock (NASDAQ:OPT), Quotes and News Summary

Q: What sector and industry does Opthea (OPT) operate in?

Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Opthea Stock (NASDAQ: OPT) stock price, news, charts, stock research, profile.

Open	$3.400
Close	-
Volume / Avg.	2.097K / 25.410K
Day Range	3.400 - 3.435
52 Wk Range	1.600 - 4.420
Market Cap	$283.350M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	-
Days to Cover	6.74

Recent News

Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sal

Avi Kapoor

Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?

Opthea Limited (NASDAQ: OPT) on Wednesday said it expects to receive the remaining $35 million committed funds under the Development Funding Agreement (DFA) with Carlyle and Abingworth, and has entered into binding documentation with a new co-investor under an Amended DFA to secure an additional

Vandana Singh

Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Opthea Limited

Sector

Health Care

Industry

Biotechnology

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused prima...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Opthea (OPT) stock?

You can purchase shares of Opthea (NASDAQ: OPT) through any online brokerage.

View our list of the best stock brokerages.

Who are Opthea's (OPT) competitors?

Other companies in Opthea’s space includes: Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Monte Rosa Therapeutics (NASDAQ:GLUE) and RAPT Therapeutics (NASDAQ:RAPT).

What is the target price for Opthea (OPT) stock?

The latest price target for Opthea (NASDAQ: OPT) was reported by Oppenheimer on Wednesday, September 13, 2023. The analyst firm set a price target for 16.00 expecting OPT to rise to within 12 months (a possible 367.84% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Opthea (OPT)?

The stock price for Opthea (NASDAQ: OPT) is $3.42 last updated Today at April 18, 2024 at 12:21 PM EDT.

Does Opthea (OPT) pay a dividend?

There are no upcoming dividends for Opthea.

When is Opthea (NASDAQ:OPT) reporting earnings?

Opthea’s H1 earnings are confirmed for Wednesday, February 28, 2024.

Is Opthea (OPT) going to split?

There is no upcoming split for Opthea.

What sector and industry does Opthea (OPT) operate in?

Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-